Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Chigenovo Co., Ltd

Clinical trials sponsored by Chigenovo Co., Ltd, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Experimental gene therapy offers hope for rare blindness condition Results expected Jan 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 3

Gene therapy injection aims to restore sight in rare blindness

Disease control Recruiting now

This study tests a gene therapy called ZVS203e for people with retinitis pigmentosa caused by a specific RHO gene mutation. The therapy is injected into the eye and uses a harmless virus to deliver a gene-editing tool. The trial includes 18 adults and will check safety and whethe…

Phase 1/2 • Sponsor: Chigenovo Co., Ltd • Aim: Disease control

Last updated Jun 27, 2026 14:00 UTC